eMedicine Specialties > General Surgery > Abdomen

Mesenteric Artery Ischemia: Treatment

Author: Deron J Tessier, MD, Staff Surgeon, Kaiser Permanente Medical Center, Fontana, CA
Contributor Information and Disclosures

Updated: Jul 8, 2009

Treatment

Medical Therapy

  • Nonocclusive mesenteric ischemia is treated medically, while acute and chronic ischemia is correctable with surgery. The first step in treating nonocclusive ischemia is identifying the underlying cause and, once found, correcting it. For instance, if a patient is found to have vasospastic disease, direct injection of papaverine into the SMA may resolve the vasospasm. If resolution with papaverine occurs, start an infusion of 30-60 mg/h.
  • Patients with refractory vasospasm may undergo surgery to improve flow to the ischemic bowel.
  • In some patients with embolic disease, intra-arterial papaverine has reversed the ischemia and averted operation.
  • If hypovolemia is considered likely, fluid resuscitation is required.
  • Start all patients with possible bowel ischemia on broad-spectrum antibiotics to cover the possibility of bowel necrosis with contamination.

Surgical Therapy

In cases of acute mesenteric ischemia, the surgeon should decide the location of viable versus nonviable bowel during surgery. Laparotomy reveals that the entire small bowel and proximal colon are affected in patients with SMA thrombosis, reflecting the proximal nature of this disorder. In contrast, patients with SMA embolization have sparing of their proximal jejunum, reflecting the more distal obstruction.

In patients with extensive bowel involvement, make every effort to retain every centimeter of viable bowel. If determining bowel viability is difficult, a second look may be required 24-48 hours later. Patients with emboli are treated with an embolectomy by exposing the SMA below the mesocolon distal to the middle colic artery. A longitudinal arteriotomy is made, and a Fogarty catheter is passed distal to the embolus, is inflated, and is used to extract the embolus. If closure of the arteriotomy is difficult, a patch graft may be used or the patient may require an endarterectomy. Other methods of reperfusion involving prosthetic bypass grafting or autogenous vein grafting have also been performed, and the reader is directed to a surgical technique manual for further discussion.

Kougias et al compared the effectiveness of balloon angioplasty and/or endovascular stenting (48 patients, 58 vessels) with that of open revascularization (96 patients, 157 vessels) in the treatment of chronic mesenteric ischemia.4 The investigators found that members of the endovascular group had a shorter hospital stay (3 days) than did patients in the open revascularization group (12 days, P <0.03) and that the 30-day mortality rate, frequency of inhospital complications, and 3-year cumulative survival rate were the same for both groups.

Three years after the procedures, however, cumulative freedom from recurrent symptoms was found in a higher percentage of open revascularization patients than in members of the endovascular group (66% vs 27%, P <0.02). The authors suggested that this was because the percentage of patients who underwent a 2-vessel procedure rather than a 1-vessel intervention was higher in the open group than in the endovascular one.

Preoperative Details

  • Patients with chronic mesenteric ischemia may have nutritional and/or electrolyte imbalances. Correct these deficiencies to prevent intraoperative and postoperative complications.
  • If possible, patients undergo bowel preparation the night before surgery and take nothing by mouth after midnight the evening before surgery.
  • In patients with acute ischemia, immediate repletion of fluids and correction of any acid-base abnormalities is necessary, followed by operation without delay.
  • All patients receive broad-spectrum antibiotic therapy prior to the operation.
  • Type and crossmatch 4 units of packed red blood cells.
  • If the angiogram shows embolic disease of the SMA, start intra-arterial papaverine.
  • A nasogastric tube may help alleviate some of the patient's pain by reducing bowel distention.
  • If the surgeon thinks a patient may require extensive resection and that lifelong hyperalimentation will be the only option, this possibility should be thoughtfully discussed with the patient and his or her family to help guide the surgeon during the exploration. These types of issues are best decided beforehand, with educated input from the patient, rather than during surgery, by the surgeon.

Intraoperative Details

  • During direct visualization of the bowel, establish viability. If the first part of the jejunum is not involved, an embolus may be present and immediate embolectomy may be indicated. Look for peristalsis, and observe the color of the bowel (pink and healthy vs red and edematous). (See image below and Image 10.) Following reconstitution of arterial flow, the viability of the bowel is reassessed. This is based on clinical findings, including the color of the bowel and the presence or absence of palpable pulses.
  • Intraoperative Doppler scans of the bowel can provide valuable information on the patency of the vessels. One gram of intravenous fluorescein followed by bowel examination under a Wood lamp can help delineate poorly perfused bowel. Institute intraoperative anticoagulation therapy with intravenous heparin.
  • The most reliable method of determining bowel viability is a second-look laparotomy. The decision to perform a second look is made during the initial exploration. If a second look is deemed necessary, the surgeon should not change his or her mind, regardless of the patient's clinical progress.


Gross specimen showing hemorrhagic dead bowel.

Gross specimen showing hemorrhagic dead bowel.

Gross specimen showing hemorrhagic dead bowel.

Gross specimen showing hemorrhagic dead bowel.

Postoperative Details

  • Monitor blood pressure and hemoglobin parameters to evaluate for sepsis or hemorrhage.
  • Continue heparin anticoagulation postoperatively to reduce thrombotic events, and papaverine may be administered to reduce vasospasm.
  • Perform a 12-lead ECG to evaluate for myocardial dysfunction.
  • Consider an echocardiogram to evaluate for valvular vegetations.
  • A patient can be expected to have a postoperative ileus because of bowel reperfusion.
  • Continuation of antibiotics postoperatively is required to prevent any septic events.

Follow-up

  • Because of the high likelihood of concomitant vascular disease in the rest of the arterial tree, patients must be closely monitored.
  • Any laboratory or radiologic examinations not previously performed in the hospital are performed in an outpatient setting.
  • The patient should have frequent visits to monitor the prothrombin time, activated partial thromboplastin time, and international normalized ratio to assure proper anticoagulation.

Complications

Because of the high prevalence of atherosclerosis, one of the most common complications involves MI. Prevent postoperative MI by identifying correctable coronary artery disease before the patient enters the operating room, if possible. During the perioperative period, use a Swan-Ganz catheter to monitor fluid and cardiac function. Finally, when cross-clamping the supraceliac aorta, notify the anesthesiologist, who can use myocardial protective maneuvers and afterload reduction to maximize cardiac output.

Acute renal failure in the immediate postoperative period can be prevented by keeping the patient well hydrated and administering mannitol before the aorta is cross-clamped.

Other possible complications include bleeding, infection, bowel infarction, prolonged ileus, and graft infection.

More on Mesenteric Artery Ischemia

Overview: Mesenteric Artery Ischemia
Workup: Mesenteric Artery Ischemia
Treatment: Mesenteric Artery Ischemia
Follow-up: Mesenteric Artery Ischemia
Multimedia: Mesenteric Artery Ischemia
References
Further Reading

References

  1. Cappell MS. Intestinal (mesenteric) vasculopathy. II. Ischemic colitis and chronic mesenteric ischemia. Gastroenterol Clin North Am. Dec 1998;27(4):827-60, vi. [Medline].

  2. Ha C, Magowan S, Accortt NA, et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. Jun 2009;104(6):1445-51. [Medline].

  3. Cappell MS. Intestinal (mesenteric) vasculopathy. I. Acute superior mesenteric arteriopathy and venopathy. Gastroenterol Clin North Am. Dec 1998;27(4):783-825, vi. [Medline].

  4. Kougias P, Huynh TT, Lin PH. Clinical outcomes of mesenteric artery stenting versus surgical revascularization in chronic mesenteric ischemia. Int Angiol. Apr 2009;28(2):132-7. [Medline].

  5. Kim MY, Suh CH, Kim ST, et al. Magnetic resonance imaging of bowel ischemia induced by ligation of superior mesenteric artery and vein in a cat model. J Comput Assist Tomogr. Mar-Apr 2004;28(2):187-92. [Medline].

  6. Aksu C, Demirpolat G, Oran I, et al. Stent implantation in chronic mesenteric ischemia. Acta Radiol. Jul 2009;50(6):610-6. [Medline].

  7. Loffroy R, Steinmetz E, Guiu B, et al. Role for endovascular therapy in chronic mesenteric ischemia. Can J Gastroenterol. May 2009;23(5):365-73. [Medline].

  8. Penugonda N, Gardi D, Schreiber T. Percutaneous intervention of superior mesenteric artery stenosis in elderly patients. Clin Cardiol. May 2009;32(5):232-5. [Medline].

  9. Mitchell EL, Chang EY, Landry GJ, et al. Duplex criteria for native superior mesenteric artery stenosis overestimate stenosis in stented superior mesenteric arteries. J Vasc Surg. Feb 20 2009;[Medline].

  10. Sivamurthy N, Rhodes JM, Lee D. Endovascular versus open mesenteric revascularization: immediate benefits do not equate with short-term functional outcomes. J Am Coll Surg. 2006;202(6):859-67.

  11. Schoots IG, Levi MM, Reekers JA. Thrombolytic therapy for acute superior mesenteric artery occlusion. J Vasc Interv Radiol. Mar 2005;16(3):317-29. [Medline].

  12. Bingol H, Zeybek N, Cingoz F, et al. Surgical therapy for acute superior mesenteric artery embolism. Am J Surg. Jul 2004;188(1):68-70. [Medline].

  13. Cooperman M, Martin EW Jr, Carey LC. Evaluation of ischemic intestine by Doppler ultrasound. Am J Surg. Jan 1980;139(1):73-7. [Medline].

  14. Eker A, Malzac B, Teboul J, Jourdan J. Mesenteric ischemia after coronary artery bypass grafting: should local continuous intra-arterial perfusion with papaverine be regarded as a treatment?. Eur J Cardiothorac Surg. Feb 1999;15(2):218-20. [Medline][Full Text].

  15. Hansen KJ, Wilson DB, Craven TE, et al. Mesenteric artery disease in the elderly. J Vasc Surg. Jul 2004;40(1):45-52. [Medline].

  16. Kihara TK, Blebea J, Anderson KM, et al. Risk factors and outcomes following revascularization for chronic mesenteric ischemia. Ann Vasc Surg. Jan 1999;13(1):37-44. [Medline].

  17. Mamode N, Pickford I, Leiberman P. Failure to improve outcome in acute mesenteric ischaemia: seven-year review. Eur J Surg. Mar 1999;165(3):203-8. [Medline].

  18. Milner R, Woo EY, Carpenter JP. Superior mesenteric artery angioplasty and stenting via a retrograde approach in a patient with bowel ischemia--a case report. Vasc Endovascular Surg. Jan-Feb 2004;38(1):89-91. [Medline].

  19. Nyman U, Ivancev K, Lindh M, Uher P. Endovascular treatment of chronic mesenteric ischemia: report of five cases. Cardiovasc Intervent Radiol. Jul-Aug 1998;21(4):305-13. [Medline].

  20. Redaelli CA, Schilling MK, Buchler MW. Intraoperative laser Doppler flowmetry: a predictor of ischemic injury in acute mesenteric infarction. Dig Surg. 1998;15(1):55-9. [Medline].

  21. Schoots IG, Koffeman GI, Legemate DA, et al. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. Jan 2004;91(1):17-27. [Medline].

  22. Seidel SA, Bradshaw LA, Ladipo JK, et al. Noninvasive detection of ischemic bowel. J Vasc Surg. Aug 1999;30(2):309-19. [Medline].

  23. Yasuhara H. Acute mesenteric ischemia: the challenge of gastroenterology. Surg Today. 2005;35(3):185-95. [Medline].

Further Reading

Related eMedicine topics:
Acute Mesenteric Ischemia
Chronic Mesenteric Ischemia
Mesenteric Artery Thrombosis
Mesenteric Ischemia
Mesenteric Venous Thrombosis

Clinical guidelines:
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). American College of Cardiology Foundation - Medical Specialty Society
American Heart Association - Professional Association
Society for Cardiovascular Angiography and Interventions - Medical Specialty Society
Society for Vascular Medicine and Biology - Medical Specialty Society
Society for Vascular Surgery - Medical Specialty Society
Society of Interventional Radiology - Medical Specialty Society.  2005.  191 pages.  NGC:004740

Clinical trials:
Biomagnetic Signals of Intestinal Ischemia
Biomagnetic Signals of Intestinal Ischemia II (SQUID)

Keywords

mesenteric artery ischemia, ischemia, mesenteric, mesenteric artery, mesentery, mesenteric ischemia, ischemic bowel, ischemic colitis, superior mesenteric artery, mesenteric thrombosis, intestinal angina, acute mesenteric ischemia, chronic mesenteric ischemia, thromboendarterectomy of the superior mesenteric artery, decreased blood supply to the small bowel, decreased blood supply to the large bowel, bowel infarction, bowel necrosis, mesenteric thromboendarterectomy, visceral atherosclerosis, acute thrombotic mesenteric artery ischemia, acute embolic mesenteric artery ischemia, visceral venous thrombosis, nonocclusive mesenteric ischemia, non-occlusive mesenteric ischemia

Contributor Information and Disclosures

Author

Deron J Tessier, MD, Staff Surgeon, Kaiser Permanente Medical Center, Fontana, CA
Deron J Tessier, MD is a member of the following medical societies: American College of Surgeons and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Burt Cagir, MD, FACS, Assistant Professor of Surgery, State University of New York, Upstate Medical Center; Consulting Staff, Director of Surgical Research, Robert Packer Hospital; Associate Program Director, Department of Surgery, Guthrie Clinic
Burt Cagir, MD, FACS is a member of the following medical societies: American College of Surgeons, American Medical Association, and Society for Surgery of the Alimentary Tract
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Michael A Grosso, MD, Consulting Staff, Department of Cardiothoracic Surgery, St Francis Hospital
Michael A Grosso, MD is a member of the following medical societies: American College of Surgeons, Society of Thoracic Surgeons, and Society of University Surgeons
Disclosure: Nothing to disclose.

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA, Vice Chairman, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital
John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract
Disclosure: AMGEN Royalty Other

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.